Open AccessAcute non‐heparin‐induced thrombocytopenia during hemodiafiltration in a patient with multiple myeloma
Author(s) -
Morita Makiko,
Nakanishi Kayoko,
Masuda Kenta,
Yoshida Kazuhiro,
Shimomura Daiki,
Ishida Atsumi,
Shiga Shuichi,
Ichiyama Satoshi
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1997
Subject(s) - medicine , heparin , hemodialysis , multiple myeloma , heparin induced thrombocytopenia , platelet , bortezomib , intensive care medicine
Key Clinical Message This report demonstrates that not only heparin‐induced thrombocytopenia, but also hemodialysis conditions (platelet activation due to hemodiafiltration and heparin underdosing) may markedly reduce the platelet count and cause clotting in the hemodialysis circuit in patients in a hypercoagulable state. The clot prevention effects of bortezomib are therefore of great importance.